ACRV icon

Acrivon Therapeutics

54 hedge funds and large institutions have $161M invested in Acrivon Therapeutics in 2024 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 14 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
54
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$1.22M
2 +$817K
3 +$331K
4
Millennium Management
Millennium Management
New York
+$278K
5
PCM
Prelude Capital Management
New York
+$264K

Top Sellers

1 -$3.83M
2 -$973K
3 -$756K
4
Charles Schwab
Charles Schwab
California
-$194K
5
UOC
UBS O'Connor
Illinois
-$182K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$58.4M
2
$37.5M
3
$15M
4
$14.9M
5
$6.22M
6
$5.67M
7
$5.51M
8
$4.46M
9
$2.12M
10
$1.58M
11
$1.39M
12
$817K
13
$814K
14
$787K
15
$738K
16
$555K
17
$539K
18
$370K
19
$321K
20
$278K
21
$264K
22
$251K
23
$238K
24
$233K
25
$216K